Recent Updates
Recently added Catalysts
BMY Positive Sentiment

Bristol Myers Squibb to Host Hematology-Focused Investor Event

Monday, November 24, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Bristol Myers Squibb has announced a virtual investor event scheduled for December 11, 2025, following the American Society of Hematology Annual Meeting. The event will focus on the company's Hematology programs, providing an overview of their development strategy and recent data. A replay of the webcast will be available shortly after the event concludes.
Price reaction · baseline $46.25 (2025-11-21 close) · hit pre-market · 1 other BMY headline(s) in the window, move may be shared
day 0 close
+3.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Bristol Myers Squibb is actively engaging with investors.
  • The event will showcase key Hematology programs.
  • The company is committed to innovative medicine.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+20%
120-day peak, hindsight
Typical move
1.7%
average across 15 past catalysts
Lead asset
Muraglitazar
Phase 3 · Type 2 Diabetes

Full Press Release Details

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that, following the conclusion of the American Society of Hematology (ASH) Annual Meeting and Exposition, the company will hold a virtual investor event on Thursday, December 11, 2025, to highlight key Hematology programs.
The company will host a webcast beginning at 9:00 a.m. ET, which is accessiblehere. Company representatives will provide investors and analysts an overview of the company’s Hematology development strategy and review recent data.
A replay of the webcast will be available athttp://investor.bms.comapproximately three hours after the event concludes. Materials related to the webcast will be available athttp://investor.bms.comat the start of the presentation.
About Bristol Myers Squibb: Transforming Patients' Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us atBMS.comand follow us onLinkedIn,X,YouTube,FacebookandInstagram.
corporatefinancial-news

Frequently Asked Questions

When is the Bristol Myers Squibb investor event?

The investor event is scheduled for December 11, 2025.

What will be discussed at the investor event?

The event will highlight key Hematology programs and development strategies.

How can I access the investor event?

The event will be accessible via a webcast starting at 9:00 a.m. ET.

Will there be a replay of the event?

Yes, a replay will be available approximately three hours after the event.

ShareAdd on Google
Tags: BMY Viatris Investor Conferences Healthcare Hematology investor event webcast American Society of Hematology
Last updated: Nov 24, 2025

Biotech snapshot

Cash runway
$11464M liquidity · $0M/mo burn
Low dilution risk
Lead asset
MuraglitazarPhase 3
Type 2 Diabetes →

Catalyst track record

+20%
best trade around BMY's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for BMY.

See every catalyst's timing & PoA →